Every 10-Q that Occidental Pet (OXY) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow OXY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OXY filings page.
Occidental Petroleum reported strong results for the quarter ended June 30, 2026, with net income of $2,996 million and net income attributable to common stockholders of $2,807 million, compared with $288 million a year earlier. Net sales from continuing operations were $8,065 million, driven mainly by higher realized crude oil prices and very strong midstream and marketing margins.
For the first six months of 2026, net income was $6,355 million and operating cash flow was $5,552 million. The all‑cash sale of OxyChem closed on January 2, 2026 for an adjusted cash sales price of $9,472 million, generating about $3.1 billion of after‑tax gain and reported as discontinued operations. After‑tax proceeds and free cash flow were used to repay $8,609 million of debt, reducing total borrowings at face value to $11,818 million and lowering interest expense. At the same time, Occidental continues to carry sizable environmental remediation liabilities of $1,853 million with a disclosed additional loss range up to $1.9 billion, and faces a tax dispute related to the $5.2 billion Tronox settlement that could require repayment of about $2.4 billion of taxes and interest if not resolved favorably.
Occidental Petroleum reported sharply higher results for the quarter, mainly due to selling its OxyChem business. Net income reached $3.4 billion, up from $945 million a year earlier, and diluted EPS rose to $3.13 from $0.77.
The all-cash OxyChem sale closed for an adjusted purchase price of about $9.5 billion, generating a $3.1 billion after-tax gain and lifting discontinued operations income to $3.1 billion. From these proceeds, Occidental repaid $6.7 billion of debt, cutting total borrowings at face value to $13.8 billion from $20.4 billion and strengthening its balance sheet.
Underlying operations were softer. Net sales from continuing operations fell to $5.2 billion from $5.7 billion, and income from continuing operations declined to $236 million from $830 million, pressured by lower commodity realizations and sizeable derivative losses, including $339 million on new crude collars. Operating cash flow from continuing operations was $1.4 billion, down from $2.0 billion, while capital spending stayed high at about $1.6 billion, mainly in oil and gas.
Occidental Petroleum (OXY) reported lower Q3 2025 results. Net sales were $6.717 billion versus $7.154 billion a year ago, and diluted EPS was $0.65 versus $0.98. Net income was $842 million versus $1.140 billion.
For the first nine months, net sales were $20.016 billion (flat year over year), operating cash flow was $7.898 billion, and capital expenditures were $5.674 billion. The company reduced total borrowings at face value to $20.815 billion from $24.391 billion, aided by $912 million of warrant exercises and asset divestitures of approximately $760 million (Permian working interests), $840 million (DJ Basin royalty/mineral interests) and $580 million (Permian gas gathering).
Occidental announced an agreement to sell OxyChem to Berkshire Hathaway for $9.7 billion in cash, subject to closing conditions, and plans to allocate the majority of after‑tax proceeds to debt reduction. As of October 31, 2025, common shares outstanding were 985,210,434. The effective tax rate was 28% in Q3, and new tax legislation (OBBB) is expected to reduce 2025 cash taxes.